GlassScriptPhysician profile
Philip C Haas
NPI 1386616613
$11,840.00
in general payments reported to CMS, 2019-2025
41 companies · $851 in 2025
The $851 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,316 · 2020: $1,253 · 2021: $1,886 · 2022: $1,641 · 2023: $1,131 · 2024: $763 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,727 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,727.41 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $2,490.54 | 2019 | |
| Abbott Laboratories | $1,946.75 | 2019-2024 | Mitraclip, Assurity, Gallant |
| Janssen Pharmaceuticals, INC | $1,269.44 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,185.09 | 2019-2025 | |
| Amgen INC. | $1,183.53 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $571.72 | 2021-2025 | Verquvo, Capvaxive |
| Boston Scientific Corporation | $442.71 | 2019-2025 | Bodyguardian, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Biotronik INC. | $348.40 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $233.29 | 2019-2025 | Farxiga, Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $189.77 | 2020-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $178.95 | 2021-2025 | Camzyos, Eliquis |
| Irhythm Technologies, INC. | $160.45 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Chiesi USA, INC. | $154.51 | 2020-2022 | |
| Esperion Therapeutics, INC. | $150.65 | 2022-2025 | Nexletol |
| Abiomed | $126.04 | 2019 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $114.15 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $98.91 | 2020-2021 | |
| Medtronic Vascular, INC. | $84.67 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $72.78 | 2019-2021 | |
| G Medical Diagnostic Services, INC. | $69.28 | 2022-2023 | Cardiac Monitoring Suite |
| Angiodynamics, INC. | $68.65 | 2024 | Auryon Laser System 100-120 Vac |
| Stryker Corporation | $57.33 | 2025 | Artix Mt, Flowtriever |
| Becton, Dickinson and Company | $54.74 | 2023 | Channel Drain |
| Pfizer INC. | $49.54 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $48.41 | 2022-2023 | Optimizer |
| Medtronic, INC. | $43.76 | 2021-2023 | Onyx Frontier |
| Baxter Healthcare | $42.38 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor |
| Osprey Medical INC | $42.32 | 2020-2021 | |
| Coala Life INC | $40.76 | 2021 | |
| Atricure, INC. | $38.92 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $36.77 | 2023 | Inpefa |
| Amarin Pharma, INC. | $34.52 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.96 | 2025 | Jardiance |
| Edwards Lifesciences Corporation | $28.84 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.36 | 2025 | |
| Inari Medical, INC. | $25.60 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cvrx, INC. | $24.90 | 2024-2025 | Barostim Neo System |
| Cardiva Medical, INC. | $24.42 | 2022 | |
| Celonova Biosciences, INC. | $19.58 | 2020 | |
| Penumbra, INC. | $15.85 | 2024 | Indigo System |
| Ekos Corporation | $13.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Haas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.